ACE and coronary artery disorder: These results are not surprising: in stable CAD with preserved left ventricular function, all strategies aimed at symptoms relief (including PCI) did not improve prognosis when added “on top” of secondary prevention therapy (statins, antiplatelet agents, and ACE-inhibitors) [16], [18].